Publications
- Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate((R)): Final report from a prospective study2018 | Second Faculty of Medicine
- FVIII inhibitor development according to concentrate: Data from the EUHASS registry excluding overlap with other studies2016 | Second Faculty of Medicine
- Pregnancy in women with congenital bleeding disorder2016 | Second Faculty of Medicine
- Inhibitor development in non-severe haemophilia across Europe2015 | Second Faculty of Medicine
- Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius2012 | Second Faculty of Medicine
- Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate (R): interim report from an ongoing prospective clinical study2011 | Second Faculty of Medicine
- Short term FEIBA prophylaxis on successful treatment of recurrent joint bleeding Case report2008 | Second Faculty of Medicine
- Pharmacokinetics, efficacy and safety of IMMUNATE (R) Solvent/Detergent (IMMUNATE (R) S/D) in previously treated patients with severe hemophilia A: Results of a prospective, multicenter, open-label phase III study2008 | Second Faculty of Medicine
- Evaluation of pharmacokinetics, efficacy and safety of Immunate (R) solvent detergent in previously treated patients with severe haemophilia A2007 | Second Faculty of Medicine
- anamnézy; defekt jednoho genu2006 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University, Third Faculty of Medicine
Loading network view...
